조영제 주입기 시장(2022-2027년) : 세계 산업 동향, 점유율, 규모, 성장, 기회, 예측

The global contrast media injectors market reached a value of US$ 1.46 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 2.16 Billion by 2027, exhibiting a CAGR of 6.30% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Contrast media (CM) injectors are medical devices utilized to inject CM into the body for enhancing the visibility of tissues for different medical imaging procedures. These procedures include computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET) or magnetic resonance. CM injectors find extensive applications in radiology, interventional cardiology, ambulatory surgical centers (ASCs), and diagnostic imaging centers across the globe. At present, they have evolved from simple, manual injectors to automated injectors that precisely control the amount of the CM agent used, facilitate automated data collection, and warn about potential hazards, such as air embolisms or extravasations.

Contrast Media Injectors Market Trends:

Increasing preferences for minimally invasive (MI) medical procedures that offer numerous benefits, such as smaller incisions, less postoperative pain, faster recovery, and shorter hospital stay, represents one of the key factors bolstering the growth of the market. Moreover, there is a rise in the use of automated CM injectors in cardiac imaging to help enhance patient safety and improve image quality. Besides this, leading players are focusing on offering personalized CM doses to patients using information from an electronic medical record (EMR) or picture archiving and communication system (PACS). This, coupled with the emergence of syringeless power injectors, which aid in reducing CM waste, is facilitating the growth of the market. Apart from this, there is a widespread prevalence of cancers, including breast, lung, colon, rectum, and prostate cancers, around the world. This, along with the increasing number of regulatory approvals of contrast agents and the significant growth in the healthcare industry, is projected to create a positive outlook for the market in the upcoming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global contrast media injectors market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, injectors type, application and end user.

Breakup by Product Type:

• Consumables
• Syringes
• Tubes
• Others
• Injector Systems
• CT Injectors
• MRI Injectors
• Angiography Injectors
• Accessories

Breakup by Injectors Type:

• Single-head Injectors
• Dual-head Injectors
• Syringeless Injectors

Breakup by Application:

• Radiology
• Interventional Cardiology
• Interventional Radiology

Breakup by End User:

• Hospitals
• Ambulatory Surgery Centers
• Diagnostics Imaging Centers

Breakup by Region:

• North America
  • United States
  • Canada

• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others

• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others

• Latin America
  • Brazil
  • Mexico
  • Others

• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being APOLLO RT Co. Ltd., Bayer AG, Bracco Imaging S.p.A., General Electric Company, Guerbet, Medtron AG, Nemoto Kyorindo Co. Ltd., Shenzhen Anke High-tech Co. Ltd., Shenzhen Seacrown Electromechanical Co. Ltd., Sino Medical-Device Technology Co. Ltd. and ulrich GmbH & Co. KG.

Key Questions Answered in This Report:

• How has the global contrast media injectors market performed so far and how will it perform in the coming years?

• What has been the impact of COVID-19 on the global contrast media injectors market?

• What are the key regional markets?

• What is the breakup of the market based on the product type?

• What is the breakup of the market based on the injectors type?

• What is the breakup of the market based on the application?

• What is the breakup of the market based on the end user?

• What are the various stages in the value chain of the industry?

• What are the key driving factors and challenges in the industry?

• What is the structure of the global contrast media injectors market and who are the key players?

• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Contrast Media Injectors Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Consumables
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Syringes
    • 6.1.2.2 Tubes
    • 6.1.2.3 Others
  • 6.1.3 Market Forecast
• 6.2 Injector Systems
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 CT Injectors
    • 6.2.2.2 MRI Injectors
    • 6.2.2.3 Angiography Injectors
    • 6.2.2.4 Accessories
  • 6.2.3 Market Forecast

7 Market Breakup by Injectors Type

• 7.1 Single-head Injectors
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Dual-head Injectors
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Syringeless Injectors
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Application

• 8.1 Radiology
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Interventional Cardiology
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Interventional Radiology
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Ambulatory Surgery Centers
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Diagnostics Imaging Centers
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 APOLLO RT Co. Ltd.
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 Bayer AG
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 Bracco Imaging S.p.A.
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 General Electric Company
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Guerbet
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 Medtron AG
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Nemoto Kyorindo Co. Ltd.
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Shenzhen Anke High-tech Co. Ltd.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Shenzhen Seacrown Electromechanical Co. Ltd.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 Sino Medical-Device Technology Co. Ltd.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 ulrich GmbH & Co. KG
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio